Skip to main content

Table 1 Patients’ characteristics

From: The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy

 

N°

Percent

Histology

 Adenocarcinoma

25

56,8

 Squamous cell carcinoma

15

34,1

 Not otherwise specified

4

9,1

T classification

 1

3

6,8

 2

15

34,1

 3

15

34,1

 4

11

25,0

N classification

 0

3

6,8

 1

5

11,4

 2

26

59,1

 3

10

22,7

Clinical stage

 IIIA

26

59,1

 IIIB

18

40,9

Total

44

100